EP Patent

EP3417912A1 — Bicyclic heteroaryl compounds

Assigned to Ariad Pharmaceuticals Inc · Expires 2018-12-26 · 7y expired

What this patent protects

This invention relates to compounds of the general formula (I) in which the variable groups are as defined herein, and to their preparation and use.

USPTO Abstract

This invention relates to compounds of the general formula (I) in which the variable groups are as defined herein, and to their preparation and use.

Drugs covered by this patent

ponatinib-hydrochloride (PONATINIB HYDROCHLORIDE)

Patent Metadata

Patent number: EP3417912A1
Jurisdiction: EP
Classification: —
Expires: 2018-12-26
Drug substance claim: No
Drug product claim: No
Assignee: Ariad Pharmaceuticals Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.